Zhejiang Xinguang Pharmaceutical Hits Day Low Amid Price Pressure at CNY 13.30

Zhejiang Xinguang Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 8.34% and reaching an intraday low of CNY 13.30. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by only 3.05% during the same period. Over the past week, Zhejiang Xinguang has shown a positive trend with a 7.29% increase, but this is overshadowed by its one-year performance, which reflects a decline of 17.49%. The company's long-term outlook appears challenging, with a five-year annual net sales growth rate of -3.15% and an operating profit decrease of 12.43%. Despite these challenges, the company reported a notable operating cash flow of CNY 85.04 million for the year, alongside a significant reduction in raw material costs, which fell by 28.39% year-over-year. The current dividend yield stands at 3.7%, and the company maintains a debt-equity ratio of -0.89, indicating a relatively low level of debt. However, with a return on equity of 6.48% and a price-to-book ratio of 1.50, the stock's valuation remains a point of consideration for stakeholders.